Rhumbline Advisers Sells 5,487 Shares of Trupanion, Inc. (NASDAQ:TRUP)

Rhumbline Advisers lessened its holdings in Trupanion, Inc. (NASDAQ:TRUP) by 5.0% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 103,331 shares of the financial services provider’s stock after selling 5,487 shares during the period. Rhumbline Advisers owned approximately 0.25% of Trupanion worth $3,038,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the business. Louisiana State Employees Retirement System increased its position in Trupanion by 2.8% in the second quarter. Louisiana State Employees Retirement System now owns 18,200 shares of the financial services provider’s stock worth $535,000 after purchasing an additional 500 shares during the last quarter. Texas Permanent School Fund Corp increased its position in Trupanion by 1.8% in the first quarter. Texas Permanent School Fund Corp now owns 31,269 shares of the financial services provider’s stock worth $863,000 after purchasing an additional 561 shares during the last quarter. CANADA LIFE ASSURANCE Co increased its position in Trupanion by 2.0% in the first quarter. CANADA LIFE ASSURANCE Co now owns 43,060 shares of the financial services provider’s stock worth $1,188,000 after purchasing an additional 830 shares during the last quarter. State Board of Administration of Florida Retirement System increased its position in Trupanion by 12.6% in the first quarter. State Board of Administration of Florida Retirement System now owns 12,726 shares of the financial services provider’s stock worth $351,000 after purchasing an additional 1,420 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in Trupanion by 14.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 11,325 shares of the financial services provider’s stock worth $313,000 after purchasing an additional 1,441 shares during the last quarter.

Insider Buying and Selling at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the sale, the chief executive officer now directly owns 99,984 shares of the company’s stock, valued at $4,647,256.32. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the sale, the chief executive officer now directly owns 99,984 shares of the company’s stock, valued at $4,647,256.32. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Fawwad Qureshi sold 640 shares of the company’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $43.12, for a total transaction of $27,596.80. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,764 shares of company stock valued at $405,238. 5.50% of the stock is currently owned by insiders.

Trupanion Price Performance

NASDAQ:TRUP opened at $46.55 on Wednesday. Trupanion, Inc. has a 1-year low of $19.14 and a 1-year high of $48.85. The company has a 50-day moving average of $39.75 and a 200 day moving average of $31.43. The firm has a market cap of $1.96 billion, a PE ratio of -72.73 and a beta of 1.74. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.63 and a quick ratio of 1.63.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.04. The business had revenue of $314.80 million during the quarter, compared to analyst estimates of $309.33 million. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. The company’s quarterly revenue was up 16.3% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.33) earnings per share. As a group, research analysts anticipate that Trupanion, Inc. will post -0.37 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on TRUP shares. Northland Securities boosted their price target on shares of Trupanion from $30.00 to $35.00 and gave the stock a “market perform” rating in a research report on Friday, August 9th. Evercore ISI upgraded shares of Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Stifel Nicolaus reiterated a “hold” rating and set a $30.00 price objective (up previously from $22.00) on shares of Trupanion in a research report on Friday, August 9th. Piper Sandler boosted their price objective on shares of Trupanion from $30.00 to $38.00 and gave the company a “neutral” rating in a research report on Friday, August 9th. Finally, William Blair assumed coverage on shares of Trupanion in a research note on Friday, July 19th. They set an “outperform” rating for the company. Four investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Trupanion has a consensus rating of “Moderate Buy” and an average target price of $36.17.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.